755 related items for PubMed ID: 32190901
21. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V, Carter B, Putman M.
Cochrane Database Syst Rev; 2018 Dec 17; 12(12):CD008901. PubMed ID: 30557452
[Abstract] [Full Text] [Related]
22. Interventions for reducing inflammation in familial Mediterranean fever.
Wu B, Xu T, Li Y, Yin X.
Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD010893. PubMed ID: 30338514
[Abstract] [Full Text] [Related]
23. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA, Mehndiratta MM, Rajabally YA.
Cochrane Database Syst Rev; 2017 Nov 29; 11(11):CD002062. PubMed ID: 29185258
[Abstract] [Full Text] [Related]
24. Interventions for infantile haemangiomas of the skin.
Novoa M, Baselga E, Beltran S, Giraldo L, Shahbaz A, Pardo-Hernandez H, Arevalo-Rodriguez I.
Cochrane Database Syst Rev; 2018 Apr 18; 4(4):CD006545. PubMed ID: 29667726
[Abstract] [Full Text] [Related]
25. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S, Sinha IP, Dwan K, Echevarria C, Schechter M, Southern KW.
Cochrane Database Syst Rev; 2015 Mar 26; (3):CD009841. PubMed ID: 25811419
[Abstract] [Full Text] [Related]
26. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V, Carter B, Putman M.
Cochrane Database Syst Rev; 2021 Aug 23; 8(8):CD008901. PubMed ID: 34424546
[Abstract] [Full Text] [Related]
27. The urinary steroidome of treated children with classic 21-hydroxylase deficiency.
Kamrath C, Wettstaedt L, Boettcher C, Hartmann MF, Wudy SA.
J Steroid Biochem Mol Biol; 2017 Jan 23; 165(Pt B):396-406. PubMed ID: 27544322
[Abstract] [Full Text] [Related]
28. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
Sellick J, Aldridge S, Thomas M, Cheetham T.
J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
[Abstract] [Full Text] [Related]
29. Urinary steroidomic profiles by LC-MS/MS to monitor classic 21-Hydroxylase deficiency.
Pussard E, Travers S, Bouvattier C, Xue QY, Cosson C, Viengchareun S, Martinerie L, Lombès M.
J Steroid Biochem Mol Biol; 2020 Apr 25; 198():105553. PubMed ID: 31778802
[Abstract] [Full Text] [Related]
30. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS, Rensen N, Gemke RJ, van Dalen EC, Rotteveel J, Kaspers GJ.
Cochrane Database Syst Rev; 2015 Aug 17; (8):CD008727. PubMed ID: 26282194
[Abstract] [Full Text] [Related]
31. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L, Prietsch SO, Ducharme FM.
Evid Based Child Health; 2014 Dec 17; 9(4):829-930. PubMed ID: 25504972
[Abstract] [Full Text] [Related]
32. Interventions for infantile seborrhoeic dermatitis (including cradle cap).
Victoire A, Magin P, Coughlan J, van Driel ML.
Cochrane Database Syst Rev; 2019 Mar 04; 3(3):CD011380. PubMed ID: 30828791
[Abstract] [Full Text] [Related]
33. Magnesium for treating sickle cell disease.
Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
Cochrane Database Syst Rev; 2019 Sep 09; 9(9):CD011358. PubMed ID: 31498421
[Abstract] [Full Text] [Related]
34. Magnesium for treating sickle cell disease.
Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
Cochrane Database Syst Rev; 2017 Apr 14; 4(4):CD011358. PubMed ID: 28409830
[Abstract] [Full Text] [Related]
35. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O.
Arq Bras Endocrinol Metabol; 2008 Feb 14; 52(1):101-8. PubMed ID: 18345402
[Abstract] [Full Text] [Related]
36. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia.
Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP.
J Clin Endocrinol Metab; 2016 Dec 14; 101(12):4690-4698. PubMed ID: 27680873
[Abstract] [Full Text] [Related]
37. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H, Stackhouse C.
Cochrane Database Syst Rev; 2020 Apr 10; 4(4):CD002201. PubMed ID: 32275788
[Abstract] [Full Text] [Related]
38. Interventions for the treatment of metastatic extradural spinal cord compression in adults.
George R, Jeba J, Ramkumar G, Chacko AG, Tharyan P.
Cochrane Database Syst Rev; 2015 Sep 04; 2015(9):CD006716. PubMed ID: 26337716
[Abstract] [Full Text] [Related]
39. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
40. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia.
Mallappa A, Sinaii N, Kumar P, Whitaker MJ, Daley LA, Digweed D, Eckland DJ, Van Ryzin C, Nieman LK, Arlt W, Ross RJ, Merke DP.
J Clin Endocrinol Metab; 2015 Mar 25; 100(3):1137-45. PubMed ID: 25494662
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
